Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.
Am J Psychiatry. 2013 Feb;170(2):180-7. doi: 10.1176/appi.ajp.2012.12030392.
The Mental Health Parity and Addiction Equity Act requires insurance parity for mental health/substance use disorder and general medical services. Previous research found that parity did not increase mental health/substance use disorder spending and lowered out-of-pocket spending. Whether parity's effects differ by diagnosis is unknown. The authors examined this question in the context of parity implementation in the Federal Employees Health Benefits (FEHB) Program.
The authors compared mental health/substance use disorder treatment use and spending before and after parity (2000 and 2002, respectively) for two groups: FEHB enrollees diagnosed in 1999 with bipolar disorder, major depression, or adjustment disorder (N=19,094) and privately insured enrollees unaffected by the policy in a comparison national sample (N=10,521). Separate models were fitted for each diagnostic group. A difference-in-difference design was used to control for secular time trends and to better reflect the specific impact of parity on spending and utilization.
Total spending was unchanged among enrollees with bipolar disorder and major depression but decreased for those with adjustment disorder (-$62, 99.2% CI=-$133, -$11). Out-of-pocket spending decreased for all three groups (bipolar disorder: -$148, 99.2% CI=-$217, -$85; major depression: -$100, 99.2% CI=-$123, -$77; adjustment disorder: -$68, 99.2% CI=-$84, -$54). Total annual utilization (e.g., medication management visits, psychotropic prescriptions, and mental health/substance use disorder hospitalization bed days) remained unchanged across all diagnoses. Annual psychotherapy visits decreased significantly only for individuals with adjustment disorders (-12%, 99.2% CI=-19%, -4%).
Parity implemented under managed care improved financial protection and differentially affected spending and psychotherapy utilization across groups. There was some evidence that resources were preferentially preserved for diagnoses that are typically more severe or chronic and reduced for diagnoses expected to be less so.
《精神健康和平等法案》和《物质使用障碍平等法案》要求在医疗保险中对精神健康/物质使用障碍治疗与一般医疗服务实行同等报销。既往研究发现,平等报销并未增加精神健康/物质使用障碍的治疗支出,反而降低了自付费用。但平等报销的效果是否因诊断而有所不同,目前尚不清楚。本文在联邦雇员健康福利计划(FEHB)实施平等报销的背景下探讨了这一问题。
作者比较了两组人群的精神健康/物质使用障碍治疗使用和支出情况,一组为 FEHB 参保者,他们在 1999 年被诊断为双相情感障碍、重度抑郁或适应障碍(n=19094);另一组为私人保险参保者,他们来自一个比较全国样本,不受该政策影响(n=10521)。为每个诊断组分别建立模型。采用差值法设计来控制长期时间趋势,更好地反映平等报销对支出和使用的具体影响。
双相情感障碍和重度抑郁患者的总支出没有变化,但适应障碍患者的支出减少了(-62 美元,99.2%置信区间[-133,-11])。所有三组患者的自付费用均有所下降(双相情感障碍:-148 美元,99.2%置信区间[-217,-85];重度抑郁:-100 美元,99.2%置信区间[-123,-77];适应障碍:-68 美元,99.2%置信区间[-84,-54])。所有诊断患者的年度总利用率(如药物管理就诊次数、精神科处方和精神健康/物质使用障碍住院天数)保持不变。仅适应障碍患者的年度心理治疗就诊次数显著减少(-12%,99.2%置信区间[-19%,-4%])。
在管理式医疗下实施的平等报销改善了财务保障,并对不同群体的支出和心理治疗利用产生了不同影响。有证据表明,资源更多地优先用于那些通常更严重或慢性的诊断,而减少用于那些预计不太严重的诊断。